Skip to main content
David Robbins, MD, Endocrinology, Kansas City, KS

DavidRobbinsMD

Endocrinology • Kansas City, KS

Diabetes, Lipid Metabolism, Thyroid

Prof of medicine, director KU Diabetes institute.

Join to view full profile

Dr. Robbins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Robbins' full profile

Already have an account?

  • Office

    3901 Rainbow Blvd
    Stop 2024
    Kansas City, KS 66160
    Phone+1 913-588-6022
    Fax+1 913-535-2101

Education & Training

  • University of Chicago Medical Center
    University of Chicago Medical Center1978 - 1980
  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1976 - 1978
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 1974 - 1976
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1974

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2005 - 2025
  • MO State Medical License
    MO State Medical License 2018 - 2025
  • DC State Medical License
    DC State Medical License 1991 - 2006
  • MD State Medical License
    MD State Medical License 1993 - 2003
  • VT State Medical License
    VT State Medical License 1975 - 1996
  • IL State Medical License
    IL State Medical License 1978 - 1982
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Awardee Kansas University school of medicine Rainbow Award best teacher, 2008
  • Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Type 1 Diabetes: Why Cases Are Expected to Double Worldwide by 2040
    Type 1 Diabetes: Why Cases Are Expected to Double Worldwide by 2040October 5th, 2022
  • Is the Newest Diabetes Treatment Always the Best?
    Is the Newest Diabetes Treatment Always the Best?August 21st, 2017
  • Big News! FDA Votes to Show Heart Benefits on GLP-1 Agonist Victoza's Label
    Big News! FDA Votes to Show Heart Benefits on GLP-1 Agonist Victoza's LabelJune 21st, 2017

Dr. David Robbins, Dr. David Robbins, MD, Dr. D Robbins